Tromsø, Norway

Rolf Seljelid

USPTO Granted Patents = 4 

Average Co-Inventor Count = 1.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Tromso, NO (2013)
  • Tromsø, NO (2002 - 2015)

Company Filing History:


Years Active: 2002-2015

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Rolf Seljelid: Innovator in Medical Applications of Glucans

Introduction

Rolf Seljelid is a notable inventor based in Tromsø, Norway. He has made significant contributions to the field of medical science, particularly through his innovative work with glucans. With a total of four patents to his name, Seljelid's inventions focus on the therapeutic applications of glucans in treating various health conditions.

Latest Patents

One of Seljelid's latest patents involves the medical uses of glucans. This invention relates to a glucan with a beta-(1,3)-backbone that has one or more beta-(1,3)-side chains linked to it. This glucan is intended for use in the treatment of asthma and related diseases affecting pulmonary function in animals. The patent also describes a method for treating these conditions by administering an effective amount of the glucan to the affected animal. Another significant patent focuses on methods of skin treatment, specifically using water-soluble β-(1,3) glucans as active agents. This method involves treating ulcers by applying a preparation that contains a water-soluble β-(1,3) glucan with β-(1,6) linked side-chains.

Career Highlights

Rolf Seljelid has established himself as a key figure in the pharmaceutical industry through his work at Biotec Pharmacon ASA. His research and inventions have contributed to advancements in medical treatments, particularly in the areas of respiratory and skin health.

Collaborations

Seljelid collaborates with various professionals in his field, including Rolf Einar Engstad, to further enhance the impact of his research and innovations.

Conclusion

Rolf Seljelid's work exemplifies the importance of innovation in medical science. His patents on glucans demonstrate a commitment to improving health outcomes through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…